10/07/2025
The journal Cancer Cell has published a study led by the Hospital del Mar Research Institute, together with researchers from GEICAM, identifying malignant cells carrying the TIM-3 protein as a central factor in their ability to generate breast cancer metastasis.
This molecule allows cancer cells to survive the most critical and challenging stage of metastasis-when they first reach a new organ-by evading immune system attacks. At the same time, it may serve as a marker of poor prognosis and metastasis risk in patients with TIM-3-positive tumors.
This discovery opens the door to the potential use of treatments that block TIM-3 to prevent metastasis before it becomes clinically evident.
July 2025
24 Thursday
Sala Marie Curie a les 15:15
July 2025
15 Tuesday
Dr. Aiguader, 88, 08003 Barcelona
See location on Google Maps
Phone: 93 316 04 00 · Fax: 93 316 04 10
info(ELIMINAR)(ELIMINAR)@researchmar.net